Skip to content
Cell Supply
Products
Ncyte® vCardiomyocytes
Ncyte® aCardiomyocytes
Ncyte® Astrocytes
Ncyte® Neural Mix
Ncyte® Endothelial Cells
Ncyte® Smooth Muscle Cells
Upcoming products
Custom Supply
iPSC generation, differentiation and expansion
Discovery Services
Solutions
Ready-to-Use Assays
Custom Screening Services
Overview Assay Capabilities
Modalities
Small Molecule
RNA Therapy
Gene Therapy
Biologics
Regenerative Medicine
Our Approach
iPSC Technology
Insights
Resources
Webinars
News
Events
About
Company
Team
Careers
Contact
Search
Cell Supply
Products
Ncyte® vCardiomyocytes
Ncyte® aCardiomyocytes
Ncyte® Astrocytes
Ncyte® Neural Mix
Ncyte® Endothelial Cells
Ncyte® Smooth Muscle Cells
Upcoming products
Custom Supply
iPSC generation, differentiation and expansion
Discovery Services
Solutions
Ready-to-Use Assays
Custom Screening Services
Overview Assay Capabilities
Modalities
Small Molecule
RNA Therapy
Gene Therapy
Biologics
Regenerative Medicine
Our Approach
iPSC Technology
Insights
Resources
Webinars
News
Events
About
Company
Team
Careers
Contact
Search
Search
HOME
insights
resources
Ncardia Resources
Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Filter
All
Scientific poster
Interview
User guide
Case study
Research
Whitepaper
Case study
March 2, 2022
Case Study: Manufacturing iPSC-derived skeletal muscle cells
Karin Langenberg
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
